查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1492237

异位性皮肤炎市场：按药物类别、给药途径、分销管道划分 - 全球预测 2024-2030

Atopic Dermatitis Market by Drug Class (Biologics, Calcineurin Inhibitors, Corticosteroids), Route of Administration (Injectable, Oral, Topical), Distribution Channel - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

异位性皮肤炎市场规模预计2023年为63.8亿美元，2024年达到67.4亿美元，预计2030年将达到95.3亿美元，复合年增长率为5.88%。

异位性皮肤炎，俗称湿疹，是一种慢性皮肤病，会导致皮肤干燥、发痒和发炎。它通常从童年开始，可能持续到成年或随着时间的推移而消失。患有异位性皮肤炎的人的皮肤通常会出现屏障功能受损的迹象，使其更容易受到感染疾病和刺激。这种情况的治疗通常包括保湿、避免触发因素以及使用处方药物控制症状和发炎。随着异位性皮肤炎在全球盛行率的不断上升，对异位性皮肤炎的需求也显着增加，异位性皮肤炎的特征是皮肤干燥、严重搔痒和发炎皮疹。此外，公众意识的提高和医疗保健支出的增加也是已开发国家和新兴国家市场扩张的主要因素。此外，政府和医疗机构的努力对于改善治疗的可近性和负担能力至关重要。然而，市场面临挑战，包括与先进治疗相关的高成本可能限制许多患者的取得。区域法规环境的复杂性也会阻碍产品的可用性并增加开发成本。儘管存在这些挑战，远端医疗的采用已成为一个重要的机会，特别是对于远距患者管理而言，从而增加了医疗服务的可近性，包括异位性皮肤炎治疗的改善。此外，向个人化医疗的转变显示出治疗效果的提高，并可能彻底改变该领域的患者照护。

主要市场统计
基准年[2023] 63.8亿美元
预测年份 [2024] 67.4亿美元
预测年份 [2030] 95.3亿美元
复合年增长率（%） 5.88%

区域洞察

异位性皮肤炎治疗的区域模式受到多种因素的影响，包括医疗基础设施、患者意识和经济多样性，并且世界各地之间存在显着差异。在美洲，对异位性皮肤炎的高度认识和已建立的医疗保健框架支持采用先进的治疗方案和持续的药物研发，透过创新配方和生技药品改善患者的治疗效果。欧洲也展现了类似的成长模式，其强有力的医疗保健政策和在简化监管核准倡议的推动下注重尖端研究。中东和非洲的医疗保健能力和意识正在提高，为异位性皮肤炎治疗市场提供了新的成长潜力。亚太地区是一个充满活力且快速发展的市场，医疗保健投资迅速增加，并且呈现出传统治疗方法与现代医疗实践融合的独特趋势。日本和澳洲拥有先进的医疗保健系统，并得到强大的皮肤科研究部门的支持，并在治疗提供方面不断创新。

FPNV定位矩阵

FPNV 定位矩阵对于评估供应商在异位性皮肤炎市场的定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对异位性皮肤炎市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析还提供了对该行业竞争性质的宝贵见解，包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在异位性皮肤炎市场中的地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 异位性皮肤炎的发生率增加
      • 食物过敏和严重异位性皮肤炎的增加
      • 开发保护皮肤屏障的新型保湿剂、生技药品及局部补脂药物
    • 抑制因素
      • 治疗费用上涨
    • 机会
      • 提高对该疾病治疗方法可用性的认识
      • 扩大各个新兴国家获得治疗的机会
    • 任务
      • 与药物使用相关的副作用
  • 市场区隔分析
    • 药物类别：抑制剂的巨大优势，疗效更高，副作用最小
    • 分销管道：由于宅配服务和折扣，网路药局越来越受欢迎
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章依药物类别分類的异位性皮肤炎市场

  • 生物製药
  • Calcineurin抑制剂
  • 皮质类固醇
  • PDE-4抑制剂

第七章 异位性皮肤炎市场：依给药途径

  • 可注射的
  • 口服
  • 话题

第 8 章 异位性皮肤炎市场：按分销管道

  • 医院药房
  • 网路药房
  • 零售药房

第九章北美和南美异位性皮肤炎市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区异位性皮肤炎市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲异位性皮肤炎市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • 强生公司透过策略收购 Proteologics 加强异位性皮肤炎和气喘的治疗选择
    • 礼来公司的 lebrikizumab 对患有异位性皮肤炎的有色人种皮肤有效
    • Glenmark 和辉瑞在印度推出新的异位性皮肤炎治疗方法
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-FE70EC183B6D

[186 Pages Report] The Atopic Dermatitis Market size was estimated at USD 6.38 billion in 2023 and expected to reach USD 6.74 billion in 2024, at a CAGR 5.88% to reach USD 9.53 billion by 2030.

Atopic dermatitis, commonly known as eczema, is a chronic skin condition causing dry, itchy, and inflamed skin. It often starts in the early childhood and can persist into adulthood or resolve over time. The individual's skin with atopic dermatitis often shows signs of a compromised barrier, making it more susceptible to infections and irritants. Management of the condition typically involves moisturizing regimens, avoiding triggers, and using prescribed medications to control symptoms and inflammation. The need for atopic dermatitis is experiencing a significant increase, with an increasing global prevalence of the condition characterized by dry skin, severe itching, and inflamed rashes. The rising public awareness and augmented healthcare spending across both developed and developing nations are also considerable factors in the expansion of the market. Moreover, government and health organizations' initiatives are pivotal in enhancing treatment accessibility and affordability. However, the market faces challenges, such as the high costs associated with advanced treatments, which may restrict access for many patients. The complexity of regulatory environments across different regions can also hinder product availability and inflate development costs. Despite these issues, the incorporation of telemedicine has emerged as a key opportunity, particularly for remote patient management, thereby increasing the accessibility of healthcare services, including atopic dermatitis treatment. Additionally, the shift towards personalized medicine showcases enhancements in treatment efficacy, which could revolutionize patient care in this field.

KEY MARKET STATISTICS
Base Year [2023] USD 6.38 billion
Estimated Year [2024] USD 6.74 billion
Forecast Year [2030] USD 9.53 billion
CAGR (%) 5.88%

Regional Insights

The geographical landscape for atopic dermatitis treatment displays pronounced variation across global regions, influenced by diverse factors such as healthcare infrastructure, patient awareness, and economic diversity. In the Americas, high awareness of atopic dermatitis and well-established healthcare frameworks support the adoption of advanced treatment options and ongoing pharmaceutical R&D, enhancing patient outcomes through innovative drug formulations and biologics. Europe displays similar growth patterns with its robust healthcare policies and an emphasis on cutting-edge research facilitated by initiatives that streamline regulatory approvals. The Middle East and Africa are advancing in healthcare capabilities and awareness, which significantly presents new growth avenues for the atopic dermatitis treatment market. The Asia-Pacific region showcases a dynamic and rapidly evolving market, with a surge in healthcare investment and a unique inclination towards integrating traditional remedies with modern medical practices. Japan and Australia, with their advanced healthcare system, continue to innovate treatment adoption, backed by strong research sectors in dermatology.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Atopic Dermatitis Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Increasing incidence of atopic dermatitis
      • Growing prevalence of food allergies intensifying atopic dermatitis
      • Development of novel moisturizers that confer skin-barrier protection, biologics, and lipid-replenishing topical drugs
    • Market Restraints
      • High cost of therapeutics
    • Market Opportunities
      • Rising awareness regarding the availability of treatments for the disease
      • Growing access to treatment in various developing countries
    • Market Challenges
      • Adverse effects associated with the use of medication
  • Market Segmentation Analysis
    • Drug Class: Significant benefits of inhibitors with higher efficacy and minimal side effects
    • Distribution Channel: Growing preferences for online pharmacies owing to home delivery services and discounts
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Atopic Dermatitis Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Atopic Dermatitis Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Johnson & Johnson's Strategic Acquisition of Proteologix to Enhance Atopic Dermatitis and Asthma Treatment Options

Johnson & Johnson Services, Inc. has announced the acquisition of Proteologix, Inc., a biotechnology company focused on developing bispecific antibodies for immune-mediated diseases. The purchase, valued at USD 850 million in cash, along with potential additional milestone payments, aims to broaden Johnson & Johnson's immunology portfolio. Proteologix boasts pivotal assets, including PX128 and PX130, as well as bispecific antibodies targeting multiple cytokines associated with atopic dermatitis (AD) and asthma. PX128, which is expected to enter phase 1 development, targets both IL-13 and TSLP, central mediators in Th2 skin inflammation and tissue inflammation, respectively. [Published On: 2024-05-16]

Eli Lilly's Lebrikizumab Demonstrates Efficacy in Skin of Color for Atopic Dermatitis

Eli Lilly and Company announced positive results from a pioneering Phase 3 clinical study of lebrikizumab aimed at treating moderate-to-severe atopic dermatitis (AD) in individuals with skin of color. Unveiled at the American Academy of Dermatology Annual Meeting, this research marks a significant stride, focusing on patient demographics often underrepresented in clinical trials. The 16-week study showcased lebrikizumab's substantive efficacy in skin clearance and itch relief among 50 participants, which aligns with prior outcomes observed in broader Phase 3 trials, thus potentially positioning lebrikizumab as a leading biologic treatment post topical therapies across diverse skin tones. [Published On: 2024-03-10]

Glenmark and Pfizer Introduce New Atopic Dermatitis Treatment in India

Glenmark Pharmaceuticals Limited, in collaboration with Pfizer Inc., has launched a novel treatment for atopic dermatitis in India named Abrocitinib. This innovative oral medication is specifically designed to offer relief to patients suffering from moderate-to-severe forms of the condition. Abrocitinib's introduction into the Indian market represents a significant advancement, addressing the unmet needs of numerous patients whose daily lives are impacted by this chronic skin disease. [Published On: 2024-01-31]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Atopic Dermatitis Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Atopic Dermatitis Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Astellas Pharma Inc., Bausch Health Companies Inc., Bayer AG, Biofrontera AG, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Galderma S.A., GlaxoSmithKline PLC, LEO Pharma A/S, Meda AB, Mylan N.V., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals, Inc, Sanofi S.A., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Atopic Dermatitis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Drug Class
    • Biologics
    • Calcineurin Inhibitors
    • Corticosteroids
    • PDE-4 Inhibitor
  • Route of Administration
    • Injectable
    • Oral
    • Topical
  • Distribution Channel
    • Hospital Pharmacies
    • Online Pharmacies
    • Retail Pharmacies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of atopic dermatitis
      • 5.1.1.2. Growing prevalence of food allergies intensifying atopic dermatitis
      • 5.1.1.3. Development of novel moisturizers that confer skin-barrier protection, biologics, and lipid-replenishing topical drugs
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of therapeutics
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising awareness regarding the availability of treatments for the disease
      • 5.1.3.2. Growing access to treatment in various developing countries
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with the use of medication
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Drug Class: Significant benefits of inhibitors with higher efficacy and minimal side effects
    • 5.2.2. Distribution Channel: Growing preferences for online pharmacies owing to home delivery services and discounts
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Atopic Dermatitis Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Biologics
  • 6.3. Calcineurin Inhibitors
  • 6.4. Corticosteroids
  • 6.5. PDE-4 Inhibitor

7. Atopic Dermatitis Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Oral
  • 7.4. Topical

8. Atopic Dermatitis Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Hospital Pharmacies
  • 8.3. Online Pharmacies
  • 8.4. Retail Pharmacies

9. Americas Atopic Dermatitis Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Atopic Dermatitis Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Atopic Dermatitis Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Johnson & Johnson's Strategic Acquisition of Proteologix to Enhance Atopic Dermatitis and Asthma Treatment Options
    • 12.3.2. Eli Lilly's Lebrikizumab Demonstrates Efficacy in Skin of Color for Atopic Dermatitis
    • 12.3.3. Glenmark and Pfizer Introduce New Atopic Dermatitis Treatment in India
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ATOPIC DERMATITIS MARKET RESEARCH PROCESS
  • FIGURE 2. ATOPIC DERMATITIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ATOPIC DERMATITIS MARKET DYNAMICS
  • FIGURE 7. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATOPIC DERMATITIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ATOPIC DERMATITIS MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY BIOLOGICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PDE-4 INHIBITOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY PDE-4 INHIBITOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ORAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY TOPICAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ATOPIC DERMATITIS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 41. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 42. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 47. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 48. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 53. CANADA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 54. CANADA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 59. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 60. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES ATOPIC DERMATITIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 82. AUSTRALIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 87. CHINA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 88. CHINA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 93. INDIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 94. INDIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 99. INDONESIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 100. INDONESIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 105. JAPAN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 106. JAPAN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. MALAYSIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 112. MALAYSIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 118. PHILIPPINES ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 123. SINGAPORE ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 124. SINGAPORE ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 130. SOUTH KOREA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. TAIWAN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 136. TAIWAN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 141. THAILAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 142. THAILAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 147. VIETNAM ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 148. VIETNAM ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA ATOPIC DERMATITIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 161. DENMARK ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 162. DENMARK ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 167. EGYPT ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 168. EGYPT ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 173. FINLAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 174. FINLAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 179. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 180. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 185. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 186. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 191. ISRAEL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 192. ISRAEL ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 197. ITALY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 198. ITALY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 204. NETHERLANDS ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 209. NIGERIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 210. NIGERIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 215. NORWAY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 216. NORWAY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 221. POLAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 222. POLAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 227. QATAR ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 228. QATAR ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 233. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 234. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 240. SAUDI ARABIA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 251. SPAIN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 252. SPAIN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 257. SWEDEN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 258. SWEDEN ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 264. SWITZERLAND ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 269. TURKEY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 270. TURKEY ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY DRUG CLASS, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM ATOPIC DERMATITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 287. ATOPIC DERMATITIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 288. ATOPIC DERMATITIS MARKET, FPNV POSITIONING MATRIX, 2023